ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yasuharu Imai
Hiromi Kurosawa
Yoshinori Takanashi
Makoto Nakazawa
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hiramatsu, T.
Right arrow Articles by Nakazawa, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hiramatsu, T.
Right arrow Articles by Nakazawa, M.

Ann Thorac Surg 2002;73:862-865
© 2002 The Society of Thoracic Surgeons

Original article: cardiovascular

Effects of dilutional and modified ultrafiltration in plasma endothelin-1 and pulmonary vascular resistance after the Fontan procedure

Takeshi Hiramatsu, MD*a, Yasuharu Imai, MDa, Hiromi Kurosawa, MDa, Yoshinori Takanashi, MDa, Mitsuru Aoki, MDa, Toshiharu Shin'oka, MDa,b, Makoto Nakazawa, MDb

a Department of Cardiovascular Surgery, Division of Pediatric Cardiac Surgery, Tokyo Women’s Medical University, Heart Institute of Japan, Tokyo, Japan
b Department of Cardiology, Division of Pediatric Cardiology, Tokyo Women’s Medical University, Heart Institute of Japan, Tokyo, Japan

Accepted for publication November 15, 2001.

* Address reprint requests to Dr Hiramatsu, Department of Cardiovascular Surgery, Tokyo Women’s Medical University, Heart Institute of Japan, 8-1 Kawada-cho, Shinjuku-ward, Tokyo, 162-8666 Japan
e-mail: shiramat{at}hij.twmu.ac.jp

Background. Pulmonary vascular resistance (PVR) is closely related with patients’ hemodynamics after the Fontan procedure and endothelin-1 (ET-1) may play an important role in pulmonary circulation. Modified ultrafiltration (MUF) is known to remove inflammatory mediators after cardiopulmonary bypass (CPB) surgery. The time courses of plasma ET-1 and PVR were examined before and after the Fontan procedure with MUF.

Methods. Twenty-two patients who underwent the Fontan procedure were divided into two groups: a dilutional ultrafiltration/modified ultrafiltration (DUF/MUF) group (n =11) and a control group (n = 11). Conventional ultrafiltration was performed during CPB in the control group. DUF was performed semicontinuously during CPB and MUF was continued until 15 to 20 minutes after the CPB with polyacrylonitonile membrane in the DUF/MUF group. The plasma ET-1 concentration was mea-sured before and after CPB, after MUF in the DUF/MUF group, and 6 and 24 hours after CPB. PVR was calculated simultaneously using a thermodilutional catheter.

Results. Plasma ET-1 levels increased significantly after CPB in the control group but they did not increase immediately after CPB in the DUF/MUF group. Similarly, PVR increased significantly after CPB in the control group but it did not increase after CPB in the DUF/MUF group and remained low at 6 and 24 hours after CPB.

Conclusions. DUF and MUF suppress the increase in the plasma ET-1 concentration that occurs immediately after the completion of the Fontan procedure and may be an effective intervention for maintaining low PVR after the procedure






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.